Neulasta® is a prescription medicine used to help reduce the chance of infection due to a low white blood cell count, in people with certain types of cancer (non-myeloid), who receive anti-cancer medicines (chemotherapy) that can cause fever and low white blood cell count.

Your doctor may prescribe Neulasta for you if you have an increased risk for serious infections. This may be the case if you: take a chemotherapy drug that puts you at risk for a serious infection called febrile neutropenia (a low level of white blood cells called neutrophils plus a fever), or.

How it's given: Neulasta can be given as an injection or as a patch applied to your skin. The injection is usually given once during each chemotherapy cycle, at least 24 hours after the last dose of chemotherapy in the cycle and 14 days before the first dose of chemotherapy in the next cycle.

Right after your strong chemo treatment, your healthcare provider will apply the on-body injector to your skin. The on-body injector is designed to automatically deliver your Neulasta® dose over 45 minutes, approximately 27 hours after application.

As of 4/14/2022, the list price for Neulasta® is $6,417.99† per dose. Neulasta® is a single dose administered once per chemotherapy cycle. Most patients do not pay the list price.

*Do not administer Neulasta® between 14 days before and 24 hours after administration of cytotoxic chemotherapy.

For Neulasta to have its best effect, it needs to go into the body 24 to 72 hours after chemotherapy.

The on-body injector is for adult patients only. dose of Neulasta. If you miss your dose or do not receive your full dose of Neulasta, you may have an increased risk of developing fever or infection.

Administration of filgrastim or pegfilgrastim within 24 hours before or after chemotherapy is not currently recommended because of the theoretical potential for increasing chemotherapy toxicity to myeloid progenitor cells after growth factor stimulation.

From ₹3,000, chemotherapy cost per cycle may go up to ₹18,000 or beyond2 as well. Patients may typically, require 4-8 chemotherapy sessions, depending on the type and stage of the cancer.

Learn more about Pegfilgrastim subcutaneous . This is a brand name drug and a generic may be available. The average cost for 1 Syringe, 0.6ml of 6mg/0.6ml each, is $8,032.49.

For the prevention of febrile neutropenia, a 6 mg dose of pegfilgrastim is given to the patient at least 24 hours after receiving chemotherapy. [1] It has two administration options; one is a pre-filled syringe and the other an on-body injector.